(5-Trifluoromethyl)-4H-1,2,4-triazol-3-amine, 95.0%, 1g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2h-pyrazolo[3,4-b]pyridine, 98%, 5g

3-BROMO-5-(TRIFLUOROMETHOXY)-1H-INDAZOLE, 95.0%, 250mg

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid, 98%, 500mg

Dimethyl Tetrafluorosuccinate>95.0%(GC)1g

5H-Pyrrolo[1,2-a]imidazol-7(6H)-one, 95+%, 1g

Hexadecylbenzene>99.0%(GC)5g

Columna HPLC NUCLEODUR® NH2-RP 3 µm, 150 mm, 1 Pieza(s)

Dimetilsulfóxido D6 con TMS (0,03 vol%), 99,8 at%D, 10 ml, envase de vidrio

2-Ethynyl-4-fluoropyridine, 95%, 1g

(E)-BENZALDEHYDE OXIME, 94%, 25g

Isoquinolin-3-ylmethanamine, 95.0%, 100mg

(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic acid, 98.0%, 5g